However, neither ibuprofen, nor the COX-2-specific inhibitor valdecoxib sensitized HNSCC cells to DAC treatment (Fig. 4A, Supplementary Fig. S4A-B). The gene discussed is PTGS2; the disease is head and neck squamous cell carcinoma.